Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
mi
from
Yakima, WA
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
mi
from
Yakima, WA
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
mi
from
Charleston, WV
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
mi
from
Charleston, WV
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
mi
from
La Crosse, WI
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
mi
from
La Crosse, WI
Click here to add this to my saved trials
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated:  9/1/2015
GSK Investigational Site
mi
from
Broadmeadow,
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Efficacy and Safety of Alvimopan 0.5mg Once Daily and 0.5mg Twice Daily for 12 Weeks for the Treatment of Opioid-Induced Bowel Dysfunction in Adults Taking Opioid Therapy for Persistent Non-Cancer Pain
Status: Enrolling
Updated: 9/1/2015
GSK Investigational Site
mi
from
Broadmeadow,
Click here to add this to my saved trials
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
Effect of Lidocaine and Esmolol Alone or in Combination to Improve the Quality of Recovery, Maintaining Hemodynamic Stability During Abdominal Surgery
Status: Enrolling
Updated:  9/3/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Effect of Lidocaine and Esmolol to Improve the Quality of Recovery
Effect of Lidocaine and Esmolol Alone or in Combination to Improve the Quality of Recovery, Maintaining Hemodynamic Stability During Abdominal Surgery
Status: Enrolling
Updated: 9/3/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Alabama Clinical Therapeutics, Llc
mi
from
Birmingham, AL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
G&L Research, LLC
mi
from
Foley, AL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
G&L Research, LLC
mi
from
Foley, AL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Adobe Gastroenterology Research, LLC
mi
from
Tucson, AZ
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Adobe Gastroenterology Research, LLC
mi
from
Tucson, AZ
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Skyline Research LLC
mi
from
Cerritos, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Skyline Research LLC
mi
from
Cerritos, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
GW Research Inc,
mi
from
Chula Vista, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
GW Research Inc,
mi
from
Chula Vista, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Paradigm Clinical, Inc.
mi
from
Garden Grove, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Paradigm Clinical, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Providence Clinical Research
mi
from
North Hollywood, CA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Providence Clinical Research
mi
from
North Hollywood, CA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Stamford Therapeutics Consortium
mi
from
Stamford, CT
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Stamford Therapeutics Consortium
mi
from
Stamford, CT
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pulmonary Associates Of Brandon
mi
from
Brandon, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pulmonary Associates Of Brandon
mi
from
Brandon, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
In Vivo Clinical Research, Inc.
mi
from
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
In Vivo Clinical Research, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Medsearch Professional Group, Inc.
mi
from
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Medsearch Professional Group, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
The Community Research Of South Florida
mi
from
Hialeah, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
The Community Research Of South Florida
mi
from
Hialeah, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Center for Gastrointestinal Disorders
mi
from
Hollywood, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Center for Gastrointestinal Disorders
mi
from
Hollywood, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology and Hepatology Associates
mi
from
Jacksonville, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology and Hepatology Associates
mi
from
Jacksonville, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Jupiter Research
mi
from
Jupiter, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Jupiter Research
mi
from
Jupiter, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Center for Advanced Gastroenterology
mi
from
Maitland, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Center for Advanced Gastroenterology
mi
from
Maitland, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Advanced Pharma CR, LLC
mi
from
Miami, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Advanced Pharma CR, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Research Institute of South Florida
mi
from
Miami, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Research Institute of South Florida
mi
from
Miami, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology Group of Naples
mi
from
Naples, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology Group of Naples
mi
from
Naples, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Palm Beach Research Center
mi
from
West Palm Beach, FL
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Georgia Clinical Research, LLC
mi
from
Snellville, GA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Georgia Clinical Research, LLC
mi
from
Snellville, GA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Elite Clinical Trials, Inc.
mi
from
Blackfoot, ID
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Elite Clinical Trials, Inc.
mi
from
Blackfoot, ID
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Medisphere Medical Research Center
mi
from
Evansville, IN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Medisphere Medical Research Center
mi
from
Evansville, IN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
MidAtlantic Medical Research Centers, Philip J. Bean Medical Center
mi
from
Hollywood, MD
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
MidAtlantic Medical Research Centers, Philip J. Bean Medical Center
mi
from
Hollywood, MD
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Boston Clinical Trials, INC.
mi
from
Boston, MA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Midwest Gastroenterology Partners
mi
from
Lee's Summit, MO
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Midwest Gastroenterology Partners
mi
from
Lee's Summit, MO
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Advanced Biomedical Research of America
mi
from
Las Vegas, NV
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Advanced Biomedical Research of America
mi
from
Las Vegas, NV
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
ActivMed Practices & Research
mi
from
Newington, NH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
ActivMed Practices & Research
mi
from
Newington, NH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
HOSC, Inc.
mi
from
Brooklyn, NY
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
HOSC, Inc.
mi
from
Brooklyn, NY
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
North American Partners in Pain Management
mi
from
Valley Stream, NY
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
North American Partners in Pain Management
mi
from
Valley Stream, NY
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Carolina Digestive Health Associates
mi
from
Davidson, NC
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Carolina Digestive Health Associates
mi
from
Davidson, NC
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Cumberland Research Associates
mi
from
Fayetteville, NC
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Cumberland Research Associates
mi
from
Fayetteville, NC
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Gastroenterology Research Consultants of Greater Cincinnati
mi
from
Cincinnati, OH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Gastroenterology Research Consultants of Greater Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Hometown Urgent Care and Occupational Health
mi
from
Groveport, OH
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Hometown Urgent Care and Occupational Health
mi
from
Groveport, OH
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Oklahoma Foundation for Digestive Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Clinical Trials Research Services, LLC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Mainline Gastroenterology Associates
mi
from
Souderton, PA
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Mainline Gastroenterology Associates
mi
from
Souderton, PA
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
ClinSearch, LLC
mi
from
Chattanooga, TN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Memphis Gastroenterology Group
mi
from
Germantown, TN
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Memphis Gastroenterology Group
mi
from
Germantown, TN
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
KRK Medical Research
mi
from
Dallas, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
KRK Medical Research
mi
from
Dallas, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Research Across America
mi
from
Dallas, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated:  9/22/2015
Pioneer Research Solutions
mi
from
Sugar Land, TX
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial in Patients With Chronic Idiopathic Constipation to Demonstrate the Efficacy and Safety of Elobixibat 5 mg and 10 mg for 26 Weeks
Status: Enrolling
Updated: 9/22/2015
Pioneer Research Solutions
mi
from
Sugar Land, TX
Click here to add this to my saved trials